The Unholy Alliance
Part Two
By Kathleen Deoul
( Page: 12 of 17)
Why would the ACS be so adamant in it's condemnation of
alternatives? One answer might be the composition of its board.
Roughly half of the American Cancer Society's board of
directors is comprised of oncologists and other medical practitioners with a
vested interest in the continued use of conventional medicine to treat cancer -
but that's not all.
More than a decade ago, the ACS established a
subsidiary, the American Cancer Society Foundation as a means of attracting
large grants from corporate donors. According to the Foundation's official
report to the U.S. government, federal form 990, its directors include Mr.
Robert A. Ingram, Vice Chairman of GlaxoSmithKline, Ms. Karen Katen, President
of Pfizer Global Pharmaceuticals and Executive Vice President of Pfizer Inc.
Gary M. Reedy, Worldwide Vice President for Pharmaceutical Policy of Johnson &
Johnson and Martin J. Murphy, Founder and CEO of AlphaMed Consulting LLC.
In its 2002 form 990, the ACS Foundation lists major
gifts from Eastman Kodak, Aventis Pharmaceuticals, Pharmacia, Merck and Company,
AstraZeneca, and Ortho Biotech. The fact that at least half of the firms,
Eastman Kodak, Aventis Pharmaceuticals, and AstraZeneca have been major
producers of the toxic chemicals that are contributing to the current cancer
epidemic doesn't seem to bother the ACS Foundation. Of course, the Foundation is
not alone among the non-profit members of the cancer establishment in its
willingness to accept money from questionable sources.
The Unholy Alliance [Part Two]
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17
The Unholy Alliance [Part One]
Contact
Kathleen Deoul, Media Matters
Email:
admin@cancer-coverup.com
|
Click here to order
